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Abstract
Non-alcoholic fatty liver disease (NAFLD) has a developmental origin and is influenced in utero. 
We aimed to evaluate if maternal diet intervention before pregnancy would be beneficial to reduce 
the risk of offspring NAFLD. In our study, female mice were either on a normal-fat diet (NF 
group), or a high-fat diet for 12 weeks and continued on this diet throughout pregnancy and 
lactation (HF group), or switched from HF to NF diet 1 week (H1N group), or 9 weeks (H9N 
group) before pregnancy. Compared to the NF offspring the H1N and HF, but not the H9N 
offspring, displayed more severe hepatic steatosis and glucose intolerance. More specifically, an 
abnormal blood lipid panel was shown in the H1N offspring and abnormal hepatic free fatty acid 
composition was present in both the HF and H1N offspring, while the H9N offspring displayed 
both at normal levels. These physiological changes were associated with desensitized hepatic 
insulin/AKT signaling, increased expression of genes and proteins for de novo lipogenesis and 
cholesterol synthesis, decreased expression of genes and proteins for fatty acid oxidation, 
increased Pcsk9 expression, and hypoactivation of AMPK signaling in the HF and H1N offspring. 
However, these effects were completely or partially rescued in the H9N offspring. In summary, we 
found that early maternal diet intervention is effective in reducing the risk of offspring NAFLD 
caused by maternal HF diet. These findings provide significant support for promoting the 
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development of effective diet intervention strategies, policy for prevention of obesity and NAFLD, 
and improvement of health outcomes for mothers and children.
Introduction
The rapid rise in obesity and associated diseases throughout the world has major negative 
impacts on human health and healthcare resources. According to data from the National 
Center for Health Statistics, 71.6% of the adult population in the United states from 2015 to 
2016 was overweight or obese in the United States (1). An estimated 18.5% of adolescents 
and US children were obese and nearly one-half of childbearing age women were 
overweight or obese (2, 3). Non-alcoholic fatty liver disease (NAFLD), regarded as the 
hepatic manifestation of metabolic syndrome, affects 10% to 24% of the general population 
in various countries. The prevalence of NAFLD is up to 75% in obese people (4). In recent 
years, the population of NAFLD patients has increased and is becoming younger, perhaps 
due to changes in diet structure and decreased physical activity (5). The American Heart 
Association Council on Epidemiology and Prevention states that obesity among girls and 
women of childbearing age is trans-generational, which may fuel the obesity epidemic for 
decades to come especially among children.
Recent study efforts have been put on investigating maternal over-nutrition to reflect the 
dietary habits of Western society. In both human and animal models, embryos exposed to 
over-nutrition during gestation have increased risks for obesity, diabetes, and other 
complications including NAFLD attributed to catch-up growth, increased adiposity, 
impaired glucose tolerance, impaired insulin sensitivity, and abnormal liver function in 
offspring (6–10). Thus, it has been suggested that prevention of obesity and its related 
diseases may need to begin before pregnancy (11–18). However, previous studies that 
evaluated pre-pregnancy dietary interventions composed of a balanced diet and regular 
physical activity only focus on the short-term effects on pregnancy outcomes, failing to look 
at the long-term effects of maternal diet on offspring (19–22).
Previously, we conducted a mouse study to evaluate if the transition of maternal diet from 
high-fat (HF) to normal-fat (NF) before pregnancy remediates the obesogenic effects of 
maternal HF diet on offspring 12-weeks post-weaning. We reported that neither a short (1-
week) nor a medium (5-week), but a long-term (9-week) diet transition, effectively avoided 
the effects of maternal HF diet on exacerbating offspring obesity, glucose intolerance, 
adiposity and adipose tissue inflammation (23–25). Additionally, we found a sex-specific 
phenotype wherein male offspring from a dam with HF-to-NF transition one week prior to 
pregnancy had more severe hepatic steatosis than male offspring exposed to a continuous 
maternal HF diet (25). These results suggested that a proper maternal adaptation period 
before pregnancy is important to “re-program” offspring energy metabolism, especially fatty 
acid metabolism in the liver. We hypothesize that starting a maternal diet transition early 
enough would be beneficial in reducing NAFLD in male offspring. Thus, the aim of this 
study was to investigate if a maternal diet intervention could release the “priming” effects of 
maternal HF diet on NAFLD observed in male offspring and to understand the underlying 
mechanisms.
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Materials and Methods
Experimental design (Table 1)
Four-week-old female mice (mixed background) were fed either a normal fat diet (10% kcal 
from fat, NF group) or a high fat diet (60% kcal from fat, HF) for 12 weeks. The female 
mice on HF diet either continued a HF diet through gestation and lactation (HF group), or 
were transferred to a NF diet at either one-week (H1N group) or nine-weeks (H9N group) 
prior to pregnancy. To ensure different diet transition periods, female mice were housed 
together with breeding males for 24 hours, at the end of diet transition period (1 week or 9 
weeks). The vaginal plug was also checked and recorded early the next morning to confirm 
if timely mating occurred. The breeding pairs were then separated and the female mouse was 
single housed until the end of lactation stage. The H1N and the H9N mothers remained on 
the NF diet through gestation and lactation. Our previous study has demonstrated a sex-
dependent phenotype of fatty liver disease in offspring mice, with female offspring only 
displaying very mild fat deposition regardless of treatment groups (24, 25). Thus, three male 
offspring were randomly selected per litter from five different litters for a total of 15 
(average litter size = 8) for each group and were given a HF diet for 12 weeks post-weaning 
prior to sacrifice. A separate group, birthed from the breeders who adhered to NF diet, was 
fed NF diet for 12 weeks and utilized as a reference control group (REF group).
Mouse experiments were conducted according to a protocol reviewed and approved by the 
Institutional Animal Care and Use Committee of the University of North Dakota and Texas 
A&M University, in compliance with the USA Public Health Service Policy on Humane 
Care and Use of Laboratory Animals.
Diet Composition
Diets were purchased from Research Diets, LLC (New Brunswick, NJ). The normal fat diet 
(Cat#D12450B) had an energy density of 3.771 kcal/g (10% fat energy, 70% carbohydrate 
energy, and 20% protein energy). The HF diet (Cat#D12492) had an energy density of 5.157 
kcal/g (60% fat energy, 20% carbohydrate energy, and 20% protein energy). The fat source 
is composed of 92% lard and 8% soybean oil.
Antibodies
Antibodies against IRS1, P-IRS1–612, AKT, p-AKT-473, PPAR-α, Srebp1, AMPK, p-
AMPK-α were purchased from Cell Signaling Technology (Cell signaling Technology, 
Danvers, MA).
Western Blots
About 100 mg of frozen tissue was homogenized in 1 ml of lysis buffer (10 mL of RIPA, 1 
complete ULTRA Tablet, 1 tablet of Phosphatase inhibitor, and 100 μL of 200 mM PMSF). 
The protein concentration was determined using a BCA protein concentration assay. 
Aliquots of 150 μg of total protein were run through routine western blots.
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Realtime-PCR (RT-PCR)
Total RNA was extracted from visceral adipose tissue using Trizol reagent (Invitrogen). 
cDNA was converted using Ready Script cDNA synthesis mix (Sigma Aldrich, St. Louis, 
MO). Primers used are listed in Table 2. RT-PCR was performed using a POWER SYBER 
Green PCR Master Mix from Applied Biosystems on a CFX384 Touch Real-Time PCR 
Detection System (BioRad Laboratories, Hercules CA). Results were analyzed using the 
ΔΔCT method with GAPDH as the normalization control (26).
Intraperitoneal Glucose Tolerance Test (IPGTT)(25)
Offspring from each experimental group were fasted overnight and were subsequently 
subjected to an IPGTT the following morning. Glucose tolerance tests were performed as 
previously reported (25, 27). Glucose tolerance was assessed by area under the curve (AUC) 
analysis.
Mass spectrometry (MS) for hepatic free fatty acid, triglyceride and cholesterol esters
Liver samples were pulverized under liquid nitrogen conditions to a fine homogeneous 
powder and about 10 mg was extracted according to the Folch procedure (28). Fatty acids 
(FA) internal standards were added before extraction. A one hundred microliter aliquot was 
subjected to saponification to release FA before UPLC-MS analysis. Fatty acids were 
resolved on the ultra-performance liquid chromatography mass spectrometer (UPLC-MS) 
column and quantified against FA stable isotope labeled internal standards using a 
quadrupole time-of-flight mass spectrometer as previously described (29, 30). Briefly, the 
liquid chromatography (LC) system consisted of a Waters ACQUITY UPLC pump with a 
well-plate autosampler (Waters, Milford, MA) equipped with an ACQUITY UPLC HSS T3 
column (1.8 μM, 100 A pore diameter, 2.1×150 mm, Waters) and an ACQUITY UPLC HSS 
T3 Vanguard precolumn (1.8 μM, 100 A pore diameter 2.1 × 5 mm, Waters). The column 
temperature was 55 °C and the autosampler temperature was 8 °C. The flow rate was 0.3 
mL/min. Solvent A consisted of acetonitrile : water (40 : 60) with 10 μM ammonium acetate 
and 0.025% acetic acid. Solvent B was acetonitrile:2-propanol (10 : 90) containing 10 μM 
ammonium acetate and 0.02% acetic acid. Solvent B was initially held at 35% for 0.1 
minutes and was then increased to 99% over 20 minutes using a linear gradient. Solvent B 
was held at 99% for 8 min before returning to initial conditions over 0.5 minutes. The 
column was equilibrated for 2.5 min between injections. The Q-TOF (Synapt G2-S, Waters) 
with electrospray ionization in negative ion mode was used for quantification. The cone 
voltage was 20 V and the capillary voltage was 1.51 kV. The source and desolvation 
temperatures were 110 °C and 350 °C respectively. The analyzer was operated with an 
extended dynamic range at 10,000 resolution (fwhm at m/z 554) with an acquisition time of 
0.1s. MSE mode was used to collect data with the T-wave element alternating between a low 
energy of 2V and a high energy state where the transfer T-wave element voltage was 10–25 
V (29). The cone gas flow rate was 10 L/h and the desolvation gas flow was 1,000 L/h. 
Leucine enkephalin (400 pg/μL, ACN:water, 50 : 50 by volume) was infused at a rate of 10 
μL/min for mass correction. MassLynx V4.1 software (Waters) was used for instrument 
control, acquisition, and sample analysis. Saturated long chain FA was quantified against 
16:0-[U-13C], medium chain FA against 14:0-d27, short chain – against 10:0-d19, mono-
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unsaturated – against 18:1-d17, di-unsaturated – against 18:2-[U-13C], and polyunsaturated – 
against 20:4-d8.
L-Carnitine detection
About 100 mg (±2 mg) of frozen liver tissue was homogenized after adding 4 mL methanol 
and 0.85 mL water per gram tissue. The methanol-chloroform method was used to separate 
the polar metabolites (upper methanol/water phase, contains L-Carnitine) and the lipophilic 
compounds (lower chloroform phase). Upper layer solvents were removed using a speed 
vacuum concentrator and under a stream of nitrogen. The samples and standard (Acetyl-d3-
L-carnitine, CDN isotopes Quebec) were analyzed on a Waters ACQUITY UPLC TQD MS 
system (Waters Corp., Milford, MA) equipped with a column heater, sample manager, 
binary solvent manager, photodiode array eλ (PDA) detector, and ESI source. Samples were 
separated on an Acquity UPLC BEH HILIC column (100 mm × 2.1 mm (i.d), 1.7 um 
particle size). The internal standards were detected in positive ion mode with source 
temperature at 150 °C, desolvation temperature at 400 °C, desolvation gas (N2) flow rate at 
700 L/h, and cone gas flow rate at 50 L/h. Capillary voltage was set at 3.5 kV and collision 
gas flow (Ar) at 0.15 L/h. Dwell time was set at 0.05 s with a span of 0.1 Da. The Cone and 
collision energy voltage, and MRM mass transitions are summarized in Table 3.
Hepatic triglyceride (TG) measurement
Blood lipid levels were measured using an Adipogenesis Detection Kit (Abcam Inc, 
#ab102513, Cambridge, UK) according to the manufacturer’s instructions and as reported 
previously (25).
Blood Lipid Panel
The mouse serum total cholesterol, free cholesterol, HDL and LDL/VLDL cholesterol levels 
were detected using an HDL and LDL/VLDL cholesterol assay kit (Abcam, Cambridge, 
UK). Following the manufacturer’s instructions, the cholesterol standard curve was prepared 
by diluting the provided cholesterol standard. The concentration of lipid was calculated 
based on the standard curve generated.
Blood C-peptide content
Blood C-peptide level was detected using the ALPCO Mouse C-peptide ELISA kit 
(ALPCO, Salem, NH) according to the user’s manual.
RNA-Seq and data analysis
Illumina next-generation sequencing was performed at University of Chicago Genomics 
Core (Chicago, USA) using Illumina HiSeq2000 instruments. The RNA-Seq data analysis 
was performed as published previously (31). Briefly, RNA-Seq short reads were mapped to 
mouse reference genome GRCm38 using a Bowtie2 package. The gene expression level was 
then quantified by a Cufflink package. The hierarchical clustering analysis (HCA) was used 
to assess the global gene-expression variations. Regression analysis was used to identify the 
genes that were correlated with the different maternal diet. Genes that showed significant 
correlation were selected by controlling the false discovery rate at 10%. The activated gene 
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pathways were analyzed using a hypergeometric distribution-based method, which was 
developed in house using R programing language. The biochemical pathway information 
was obtained from KEGG (www.genome.jp/kegg).
Statistical Analysis
Measurements for single time points were analyzed by Fisher’s least significant difference 
test to take into account the multiple comparisons between groups REF, NF, HF, H1N, and 
H9N. Fisher’s least significant difference test was performed by first carrying out a one-way 
analysis of variance for all treatment groups. For the longitudinal data such as body weight, 
a linear mixed model was used for the analysis of repeated measures with each individual 
mouse as a random effect. A p-value less than 0.05 is considered a significant difference, 
while a p-value less than 0.1 is considered a marginal significance. All analyses were carried 
out using SAS JMP software (SAS Institute Inc., Cary, NC, USA). Data is presented as 
Mean ± SE.
Results
The H1N diet resulted in rapid body weight gain and glucose intolerance in male offspring, 
while the H9N diet only caused moderate body weight gain
The weekly food consumption (Fig 1A) of male offspring mice was recorded for calculating 
the weekly energy consumption via diet (Fig 1B). Food consumption was the same among 
all groups; however, the energy consumption of the REF group on post-weaning NF diet was 
significantly lower than the other four groups on post-weaning HF-diet (Figs 1A and B). The 
energy consumption among NF, HF, H1N and H9N groups were not different (Fig 1B). The 
offspring mice were weaned at similar body weights. On the post-weaning HF-diet, all 
offspring constantly gained weight during the 12-week experimental period, with H1N 
offspring gaining the fastest. Longitudinal analysis of repeated measurements showed that 
H1N offspring gained significantly more weight than the REF or NF offspring. Interestingly, 
both the HF offspring and the H9N offspring weighed marginally more than the REF 
offspring (Fig 1C, P = 0.093 for the HF offspring and P = 0.071 for the H9N offspring). We 
further weighed the posterior subcutaneous fat tissue and the gonadal adipose tissue of the 
offspring mice. The results showed significantly more visceral fat in the NF, HF and H1N 
offspring compared to the REF offspring, with the H1N offspring having the largest amount 
(Fig 1D). The amount of subcutaneous fat pad from the highest to the lowest rank is H1N > 
H9N ≈ HF ≈ NF ≈ REF (Fig 1D).
The IPGTT was performed on the offspring at the end of week 9. At this time point, all 
offspring had similar fasting glucose levels (Fig 1E). The NF offspring were glucose tolerant 
at checkpoint; however, neither the HF nor the H1N offspring were glucose tolerant (Figs 1E 
and F). In contrast, the H9N offspring were glucose tolerant (Figs 1E and F). Similarly, the 
H1N offspring, but not the H9N nor HF offspring, had higher levels of blood C-Peptide than 
that of the REF offspring. (Fig 1G).
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The maternal HF and H1N diets resulted in hepatic steatosis and a disrupted lipid panel in 
male offspring, while the maternal H9N diet avoided such effects
We next evaluated if lipid metabolism in the liver was affected by different maternal diet 
transitions before pregnancy. Histology showed that the NF offspring only had 
microvesicular fat in hepatocytes instead of visible ballooning cells, in which the nuclei 
remain centrally located and appeared to be indented by the small fat droplets (Fig 2A). 
However, hepatic steatosis was observed in both HF and H1N offspring along with 
ballooning cells that indicated intracellular lipid accumulation. In contrast, fatty acid 
accumulation was not visible in hepatocytes of the H9N offspring.
Using a high-resolution UPLC-MS/MS method, we determined whether the major hepatic 
long or very long chain free fatty acid (FFA) panel (chain lengths of 12–24 carbons) was 
affected by different maternal diet interventions before pregnancy (Figs 2B–H). The total 
FFA was significantly greater in H1N and HF offspring than in the NF offspring (Fig 2B). In 
addition, the saturated FFA (SFA) in the liver of H1N and HF offspring was higher than that 
of NF offspring (Fig 2B). Of note, the H1N and HF offspring displayed higher amounts of 
monounsaturated FFA (MUFA) and polyunsaturated FFA (PUFA). Generally, the HF and 
H1N diets increased most of the major SFA (Fig 2C), MUFA (Fig 2D) and PUFA (Fig 2E), 
while the H9N diet avoided such effects in the FFA panel in hepatocytes. Importantly, 
offspring of NF, HF, and H1N groups significantly enhanced the ratio of oleic acid (18:1) to 
stearic acid (18:0) compared to REF offspring whereas H9N offspring had the level 
recovered (Fig 2F). In addition, the HF diet significantly decreased the ratio of C18:0 to 
C16:0. Compared to the NF offspring, the level of C18:0 to C16:0 in HF offspring was 
similar, but this ratio was much lower in H1N offspring when compared to NF offspring. 
However, H9N offspring had no changes in this ratio (Fig 2G). These results suggest that 
maternal diet differentially affects the hepatic FFA panel in offspring, not only in quantity 
but also in FFA subtype.
With a disruption of the hepatic FFA panel, we asked if the hepatic TG content was also 
altered by different maternal diet interventions. The NF offspring had higher TG content in 
the liver, showing a positive effect of post-weaning HF diet (Fig 2H). Both the HF and H1N 
offspring had increased TG content. Surprisingly H9N offspring had lower TG content than 
NF offspring, which made it a level similar to REF offspring (Fig 2H). We further measured 
several major types of TG and found that the NF, HF, and H1N groups were unable to be 
clustered, which were distinct from the cluster of H9N and REF offspring (Fig 2I).
The H1N offspring had disrupted blood lipids, which were normal in the H9N offspring
We wondered if the disrupted hepatic FFA and TG panel in HF and H1N offspring was 
associated with disrupted blood lipid levels. The post-weaning HF diet (NF vs. REF) did not 
affect the total cholesterol (TC) (Fig 3A), total amount of free cholesterol (FC) (Fig 3B) or 
blood VLDL and LDL content (VLDL+LDL) (Fig 3C), but significantly decreased HDL 
content (Fig 3D). The ratio of TC/HDL and (LDL+ VLDL)/HDL were known to be 
associated with a higher risk of cardiovascular disease (32). The maternal HF diet did not 
seem to change the blood lipid panel. However, H1N offspring had all six biochemical 
parameters significantly increased. In contrast, H9N offspring had an entirely normal lipid 
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panel (Figs 3A–F). With an overall similar trend to the blood lipid panel, the hepatic 
cholesterol ester content from the highest to the lowest was H1N > HF ≈ NF > REF ≈ H9N 
(Fig 3G).
RNA-Seq analysis identified significant KEGG pathways involving lipid metabolism by 
different maternal diet interventions
Next, we investigated the molecular mechanism contributing to the phenotypical differences 
between H1N and the H9N offspring. For each sample, 20–25 million short reads were 
generated using Illumina HiSeq 2000, and >90% of short reads were mapped to the mouse 
reference genome GRCm38. Hierarchical clustering analysis of the 2,000 genes with the 
largest variance across the groups showed that HF and H1N had similar transcript profiles. 
The H9N offspring clustered with the H1N and the HF groups, which are distinct from the 
NF offspring (Fig 4A). We found 4458, 3314, and 3707 differentially expressed genes 
(DEGs) for HF, H1N and H9N respectively when compared with NF offspring using a false 
discovery rate 0.05 as the cutoff. There were 2,466 DEGs overlapping between the 
comparisons of HF and H1N versus NF, as shown by Venn diagram. There were 2,191 
DEGs overlapping between H9N and H1N versus NF. The number of overlapped DEGs 
between the comparisons of H9N and HF versus NF was 2,134. There were 1,624 
overlapping DEGs among all three comparisons (Fig 4B).
In addition, gene ontology (GO) analysis identified distinct KEGG (Kyoto Encyclopedia of 
Genes and Genomes) pathways following HF, H1N, and H9N diets. We noticed several 
significant KEGG pathways were involved in lipid metabolism and homeostasis, including 
NAFLD, fat digestion and absorption, fatty acid elongation, fatty acid degradation, linoleic 
acid metabolism, biosynthesis of unsaturated fatty acids, oxidative phosphorylation, 
cholesterol metabolism, steroid hormone biosynthesis, primary bile acid synthesis, bile 
secretion, and glycerolipid metabolism (Fig 4C). Overall, HF offspring had more DEGs of 
the significant pathways than H1N offspring, which had more DEGs than H9N offspring. 
Compared to the NF offspring, three pathways (NAFLD, oxidative phosphorylation and 
cholesterol metabolism) had more than or close to 50% of DEGs in HF offspring, while the 
number decreased in H9N offspring to half of that of HF offspring. The H1N offspring had 
the lowest percentile of DEGs in the pathways for fatty acid elongation and fatty acid 
degradation. There were also pathways with similar or slightly lower percentage of DEGs 
among HF, H1N, and H9N offspring including linoleic acid metabolism, biosynthesis of 
unsaturated fatty acid, steroid hormone biosynthesis, primary bile acid biosynthesis, and bile 
secretion. Among all these pathways, only the pathway for oxidative phosphorylation was 
insignificantly associated with the H9N diet (Fig 4D). We further performed a hierarchical 
clustering analysis to show that the DEGs, involved in the mentioned signaling pathways for 
lipid metabolism, of H1N offspring clustered together with HF offspring, which further 
grouped with those of H9N offspring (Fig 4E). The DEGs of NF offspring was distinct from 
the hierarchy of HF, H1N, and H9N. These results suggest that different maternal diets 
differentially affected the lipid metabolism at the mRNA level.
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The maternal HF and H1N diets increased the gene expression for fatty acid and 
cholesterol biosynthesis while the H9N diet had no such effects
To confirm that different maternal diet transition strategies affect lipid metabolism 
differently at the gene expression level, we first measured the expression of key lipogenesis 
genes. Insulin promotes lipogenesis by activation of sterol regulatory element binding 
protein 1c (SREBP1c), a transcription factor that promotes the expression of lipogenic genes 
including Fasn and Acc (33). The HF and H1N offspring had significantly higher levels of 
SREBP1c than REF offspring, and its level in HF offspring was higher than that of NF 
offspring. However, the H9N offspring had a similar amount of SREBP1c as the NF and 
REF offspring (Fig 5A). The changes of Srebp1c found at the RNA level were similar to 
levels measured at the protein level (Fig 5B, Srebf1). Consistently, we observed significantly 
enhanced Fasn, Acc1, and Acc2 expression in the HF and H1N hepatocytes versus the NF 
hepatocytes, whereas these gene expression changes were either completely (Acc1 and 
Acc2) or partially (Fasn) returned to normal in H9N offspring hepatocytes (Fig 5B). We 
further measured two important genes, one for fatty acid elongation (Elovl6) and the other 
for fatty acid desaturation (Scd1). The Elovl6 expression was remarkably elevated in HF and 
H1N offspring versus NF offspring, while completely recovered in H9N offspring (Fig. 5B). 
Similarly, HF and H1N offspring had higher expression of Scd1 than NF offspring, while 
H9N offspring expressed a similar level of Scd1 as NF offspring. In addition, Cd36, an 
important gene encoding fatty acid translocase for selective cholesteryl ester and fatty acid 
uptake, was upregulated in H1N offspring compared to NF offspring, while HF and H9N 
offspring had similar expression levels (Fig 5B).
Srebp-2 is an important transcription factor that regulates cholesterol metabolism (34). The 
Srebp-2 expression was higher in the HF and H1N offspring compared to NF offspring liver 
while H9N offspring had expression levels similar to NF offspring (Fig 5C). We further 
assessed the expression of key genes encoding the rate-limiting enzyme for de novo 
cholesterol biosynthesis, Hmgcr and Hmgcs1. Clearly, both the HF and H1N diet 
significantly enhanced the expression of both genes, while the H9N diet avoided such effects 
(Fig 5C). Cyp51a1 is the only cytochrome P450 enzyme involved in de novo cholesterol 
biosynthesis (35). Expression of Cyp51a1 was significantly higher in HF and H1N offspring 
compared to NF offspring, while Cyp51a1 expression was partially retracted in H9N 
offspring. (Fig 5C HF vs. H9N: 7.129 ± 0.509 vs. 3.230 ± 0.363, P < 0.05). These results 
suggested an increase in de novo cholesterol biosynthesis in HF and H1N offspring.
Furthermore, we observed a 9-fold increase in Pcsk9 expression in HF (10.04±0.12) and 3-
fold increase in H1N offspring (3.97±0.15) compared to NF offspring (1.00±0.23). In 
contrast, only a 2-fold increase was measured in H9N offspring (2.98±0.61) (Fig 5D). We 
did not detect expression differences of Abca1 and Ldlr among the groups.
The HF and H1N diet desensitized the Insulin/AKT signaling in liver, while the H9N diet 
avoided such effects
In hepatocytes, insulin sensitivity was disrupted by the post-weaning HF diet, evidenced by 
over-phosphorylation of IRS1 at Ser636 (p-IRS1636) in the NF offspring. The maternal HF 
and H1N diets further over-phosphorylated IRS1 at Ser636 (Figs6 A–C) and thus resulted in 
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the inhibition of insulin signaling that dephosphorylates its downstream p-AKT at Ser473 
(Figs 6A and E). In contrast, the maternal H9N diet avoided such effects by normalizing the 
phosphorylation of IRS1 and its downstream AKT. Furthermore, we measured several key 
genes whose hepatic expression reflects insulin sensitivity including Igf1, Insig1, Insig2a, 
Insr, Lepr, Adipor1, and Adipor2. Both the maternal HF and the H1N diet significantly 
decreased the expression of Lepr, Adipor1, and Adipor2 in offspring liver (Fig 6F). 
However, their expressions were recovered in H9N offspring (Fig 6F). Although there was a 
decreasing trend for the expression of Igf1, Insig1, Insig2a, and Insr in the HF and H1N 
offspring versus the NF offspring, the changes were not significant. To be noted, the 
expression of Insig2a (0.722 ± 0.039 vs. 1.412 ± 0.118, p < 0.05 compared to H1N group) 
and Igf1 (0.731 ± 0.020 vs. 1.188 ± 0.122, p < 0.05 compared to H1N group) in H9N 
offspring was significantly higher than H1N offspring and was similar to the REF offspring.
The maternal HF and H1N diets inhibited hepatic AMPK signaling activity and decreased 
expression of β-oxidation related genes, while the H9N diet avoided such effects
We measured the activity of AMPK signaling to evaluate if changes in lipid metabolism in 
HF, H1N, and H9N offspring were associated with its deactivation or overactivation. We 
observed decreased AMPK expression in the NF offspring, but not the other groups (Figs 7A 
and B). The results showed a decreased ratio of p-AMPK-α/GAPDH, in the NF, HF, and 
H1N groups compared to the REF offspring (Figs 7A and C). The levels of p-AMPK-α/
AMPK-α was significantly lower in HF and H1N offspring than NF or REF offspring (Figs 
7A and D). However, these ratios in H9N offspring were not different from REF or NF 
offspring (Figs 7D and E). These results suggested that the HF and H1N diet, but not the 
H9N diet, deactivated AMPK signaling.
Next, we evaluated the level of β-oxidation in the liver by measuring the expression of key 
modulators and genes involved. Compared to NF offspring, both HF and H1N offspring 
decreased expression of PPAR-α protein in the liver, while H9N offspring had a similar 
expression of PPAR-α (Fig 7E). Consistently, L-Carnitine content in the liver significantly 
decreased in the HF offspring while significantly increased in the H9N offspring compared 
to NF offspring (Fig 7F). In addition, we measured the expression of key genes for fatty acid 
degradation and β-oxidation, which include Cpt1a, Cpt1b, Cpt2, Hmgcs2, Acsl1, and 
Mlycd. Significantly lower expressions of Hmgcs2 and Acsl1 were observed in HF offspring 
compared to NF offspring. In addition to Hmgcs2 and Acsl1 downregulation, H1N offspring 
also had decreased hepatic expressions for Cpt1a, Cpt1b, and Cpt2 (Fig 7G). Importantly, 
the expression of all these genes in H9N offspring were not different from NF offspring. 
These results suggest an inhibition of β-oxidation in the HF and H1N offspring liver, which 
was not observed in the H9N offspring.
Discussion
Previous animal studies have shown that western-style obesogenic diets prime NAFLD in 
offspring adulthood (24, 25, 36–43), providing strong evidence that greater focus is needed 
on maternal metabolic health prior to and during pregnancy. Thus, it is important to know 
the long-term effectiveness and etiology of maternal pre-pregnancy dietary intervention on 
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mitigating the deleterious effects of maternal HF diet on offspring NAFLD risk. This new 
knowledge will promote the development of effective diet intervention strategies and policy 
for prevention of obesity and NAFLD and improvement of health outcomes for mothers and 
children. In the current study, we showed that the HF and H1N offspring had more severe 
hepatic steatosis than the NF and H9N offspring, suggesting that simply switching to a NF 
diet before pregnancy and not allowing a proper transition period was not beneficial in 
reducing the risk for offspring NAFLD. In our model, the H1N diet causes an even more 
severe phenotype of metabolic dysregulation than the HF and NF offspring, evidenced by 
more body weight gain, glucose intolerance, hepatic steatosis, and hyperlipidemia. However, 
the H9N diet has a beneficial effect indicated by glucose tolerance, no NAFLD, and normal 
blood lipid panel in offspring. In humans, the diagnosis of NAFLD is strongly predictive of 
insulin resistance (44, 45). Similarly, the HF and H1N hepatocytes were less sensitive to 
insulin signaling due to inhibited Insulin/Akt signaling and lower expression of genes 
responsible for insulin sensitivity. In contrast to the HF and H1N diet, the H9N diet did not 
cause these damaging effects of maternal HF diet by promoting normal Insulin/Akt signaling 
and a normal expression of genes involved in insulin signaling.
We found that different maternal diet interventions differentially affected the offspring lipid 
panel. Abnormal cellular lipid composition is lipotoxic as it can lead to toxic lipid 
accumulation, organelle dysfunction, cell injury, and chronic inflammation (46, 47). Taking 
into account that TG is an inert form of lipid storage that protects against lipotoxicity (48), 
changes in hepatic FFAs of offspring is critical for understanding how different maternal diet 
interventions led to different phenotypes of NAFLD. The significantly elevated total amount 
of FFAs in offspring liver by the HF diet and H1N diet, and the normal amount of FFAs by 
the H9N diet suggest that different maternal diets before pregnancy prime the quantity of 
hepatic FFAs in offspring. In addition to quantity, the composition of FFAs is various among 
groups treated with different maternal diet interventions. In our model, increased MUFAs 
and PUFAs in HF and H1N offspring versus NF offspring, suggests that maternal diets 
prime the desaturation of SFAs. It is not clear if the increasing MUFAs and PUFAs are 
simply due to overall higher amount of SFAs as substrates, or due to enhanced desaturation 
activity in these offspring. We also reported two associations: one between increased C18:1/
C18:0 ratio and increased expression of Scd1, and the other between decreased C18:1/C18:0 
ratio and increased expression of Elovl6. Both trends were seen in HF and H1N offspring, 
but not among H9N offspring. The association between C18:1/C18:0 ratio and Elovl6 
expression might suggest and be explained by a deactivation of Elovl6 enzyme in the HF 
and H1N offspring which was averted in H9N offspring. Actually, while Elovl6 gene 
overexpression promotes steatohepatitis (49), increased C16:0 from C14:0 with decreased 
activity of Elovl6 enzyme is recently reported in the liver of NASH patients (50). 
Noteworthily, previous human studies of NAFLD patients reported increased SFAs, MUFAs, 
C18:1/C18:0 ratio, and decreased C18:0/C16:0 ratio associated with the severity of NAFLD 
(50–52). Our HF and H1N offspring displayed changes of the mentioned biomarkers in 
parallel with more severe hepatic steatosis than H9N and NF offspring, confirming this 
association reported in human studies. This suggests new biomarkers for the progression of 
NAFLD.
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Our study discloses the various mechanisms through which different maternal diets prime 
lipid metabolism in offspring liver. A previous study has shown that hepatic de novo 
lipogenesis (DNL) is marginal in fetal liver and the expression of genes involved in DNL is 
not significantly changed with over-nutrition exposure in utero (53). In our study, the HF and 
H1N offspring had desensitized insulin signaling, higher expression of genes involved in 
DNL and de novo cholesterol synthesis, and increased Srebp-1 expression under post-
weaning HF diet compared to the NF offspring. This result is consistent with multiple 
studies showing that in utero exposure to HF diet primes hepatic lipid metabolism under 
malnutrition, such that it worsens the NAFLD phenotype in offspring fed on post-weaning 
HF diet (40, 41, 54–56). To be noted, the H9N diet but not the H1N diet avoided the adverse 
effects of maternal HF diet to alter the molecular markers of lipogenesis. These results 
support the concept that maternal diet during the gestational and pre-pregnancy stage 
potentiates postnatal metabolic liver disease via modification of hepatic lipogenesis. We also 
identified the deactivation of FA oxidation to be the cause of hepatic lipid accumulation seen 
in HF and H1N offspring. Others have demonstrated that adult mice previously exposed to 
overnutrition in utero display decreased FA oxidation under postnatal HF diet (55, 57). In 
our study, the deactivation of AMPK signaling, decreased expression of PPAR-α and genes 
involved in FA oxidation in HF and H1N offspring, suggesting an inability to sufficiently 
increase β-oxidation in response to over-nutrition. These molecular changes were not noted 
in the H9N offspring liver. Thus, modification of the capability for FA oxidation could be 
another molecular mechanism that potentiates postnatal NAFLD in offspring of maternal 
overnutrition. Interestingly, most of the lipogenesis genes showed higher expressions in the 
HF offspring than the H1N offspring, while the expression level of genes involved in β-
oxidation was more down-regulated in H1N offspring. These results suggest that maternal 
HF or H1N diet have different modes of pathological action, either by downregulating fatty 
acid oxidation more (H1N diet), or by inducing lipogenesis more (HF diet). Similar 
discrepancy between H1N and HF offspring was also noted in the molecular events involved 
in β-oxidation. Such that, the HF diet yielded lower content of L-carnitine, while the H1N 
diet inhibited expression of genes involved in β-oxidation.
In addition, different maternal diets seemed to result in different capacities for hepatic 
lipoprotein metabolism. Enhanced expression of Pcsk9 was found in HF, H1N, and H9N 
offspring with the lowest increase seen in H9N offspring. PCSK9 binds to the receptor for 
low-density lipoprotein particles (LDLR), which blocks its binding with the LDL-particles, 
preventing hepatic uptake (45). Thus, these results suggest a higher potential for NF 
offspring to process lipoprotein than those offspring (HF, H1N, and H9N) from mothers 
exposed to HF diet previously. Indeed, H1N offspring had an abnormal blood lipid panel 
with hepatic steatosis. The HF offspring had hepatic steatosis, while NF and H9N offspring 
had generally normal lipid panel and no hepatic steatosis. In H9N offspring, lipid 
metabolism was balanced with DNL, FA oxidation level, and Pcsk9 expression partially 
recovered. This potential mechanism needs to be confirmed by future studies focused on 
evaluating the effects of different maternal diets on lipoprotein metabolism. Nonetheless, our 
results suggest that different maternal diets prime offspring lipid metabolism differently.
In summary, our study indicates that an early maternal diet intervention is effective in 
reducing the risk for offspring NAFLD caused by maternal HF diet. Clinically, this 
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encouraging discovery may provide valuable data-supported evidence for designing clinical 
trials to evaluate urgently required intervention strategies to minimize the vicious cycle of 
obesity and its related metabolic complications for future generations.
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Figure1. The H1N diet resulted in rapid body weight gain and glucose intolerance in male 
offspring, while the H9N diet only caused moderate body weight gain.
1A. Food consumption of male offspring mice was recorded weekly since post-weaning for 
12 weeks.
1B. Energy consumption was calculated weekly since post-weaning for 12 weeks.
1C. Body weight of male offspring was recorded weekly since post-weaning for 12 weeks.
1D. Posterior subcutaneous and gonadal adipose tissue of male offspring mice were 
collected and weighed.
Zhou et al. Page 17
Lab Invest. Author manuscript; available in PMC 2020 May 20.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
1E. IPGTT was conducted on male offspring mice at the end of 9 weeks of post-weaning HF 
diet.
1F. Area under the curve (AUC) was calculated for the results of IPGTT in male offspring 
mice.
1G. Blood C-Peptide was measured in male offspring mice.
Data is presented as Mean ± SE, n=15 from five litters. * P<0.05 vs. REF group. # P<0.05 
vs. NF group.
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Figure2. The maternal HF and H1N diets resulted in hepatic steatosis and a disrupted lipid panel 
of male offspring, while the maternal H9N diet avoided such effects.
2A. HE staining was performed on the liver tissue of male offspring mice.
2B-E. The major hepatic long or very long chain free fatty acid (L/VLCFFA) panel (chain 
lengths of 12–24 carbons) were measured via high-resolution UPLC-MS/MS method after 
Folch extraction.
2F. The relative amount of oleic acid (18:1) on the stearic acid (18:0) was calculated by 
dividing the amount of oleic acid with the amount of stearic acid.
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2G. The ratio of stearic acid (18:0) to the palmitic acid (16:0) was calculated by dividing the 
amount of stearic acid with the amount of palmitic acid.
2H. Hepatic TG content was detected in male offspring mice.
2I. A heatmap for the types of TG detected via high-resolution UPLC-MS/MS method was 
generated by cluster analysis.
Data is presented as Mean ± SE, n = 5 from 5 litters. * P<0.05 vs. REF group. # P<0.05 vs. 
NF group.
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Figure3. The H1N offspring had disrupted blood lipids, which were normal in the H9N offspring.
3A-D. The blood lipid panel of male offspring mice including the amount of total 
cholesterol (TC), free cholesterol (FC), LDL/VLDL, and HDL was detected using a 
cholesterol assay kit from Abcam.
3E. The ratio of (VLDL+LDL)/HDL was calculated by dividing the sum of VLDL and LDL 
with the amount of HDL.
3F. The ratio of TC/HDL was calculated by dividing the amount of TC with the amount of 
HDL.
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3G. The hepatic cholesterol of male offspring mice was detected using a cholesterol 
detection kit from Sigma.
Data is presented as Mean ± SE, n=5 from 5 litters. * P<0.05 vs. REF group. # P<0.05 vs. 
NF group.
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Figure4. RNA-Seq analysis identified significant KEGG pathways involving lipid metabolism by 
different maternal diet interventions.
4A. RNA-seq analysis using Illumina HiSeq 2000 were performed on NF, HF, H1N and 
H9N offspring livers. Hierarchical clustering analysis was performed on the top 2,000 
DEGs.
4B. DEGs for HF, H1N and H9N when compared with NF offspring using false discovery 
rate 0.05 as the cutoff. DEGs overlapping among the comparisons of HF, H1N and H9N 
versus NF was shown by Venn diagram.
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4C. Gene ontology (GO) analysis identified distinct KEGG (Kyoto Encyclopedia of Genes 
and Genomes) pathways by HF, H1N, and H9N diets. The percentile of DEGs in each 
pathway are plotted.
4D.The –Log (p-value) of the altered KEGG signaling pathway are plotted.
4E. DEGs involved in the lipid metabolism signaling pathways were analyzed by 
Hierarchical clustering analysis.
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Figure 5. The maternal HF and H1N diets enhanced expression of genes in fatty acids and 
cholesterol biosynthesis while the H9N diet avoided such effects.
5A. The expression of SREBP1c in liver tissue was measured by western blots of male 
offspring mice.
5B. The hepatic expression of Srebf1, Fasn, Acc1, Acc2, Elovl6, Scd1, and Cd36 of male 
offspring mice was measured by RT-PCR.
5C. The hepatic expression of Srebf2, Cyp51, Hmgcr, and Hmgcs1 of male offspring mice 
was measured by RT-PCR.
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5D. The hepatic expression of Abca1, Ldlr and Pcsk9 of male offspring mice was measured 
by RT-PCR.
Data is presented as Mean ± SE, n = 5 from 5 litters. * P < 0.05 vs. REF group. # P < 0.05 
vs. NF group.
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Figure6. The HF and H1N diet desensitized Insulin/AKT signaling in liver disrupted by post-
weaning HF diet, while the H9N diet avoided such effects.
6A. The expression of IRS-1, phosphorylation of IRS-1 at Ser636, the expression of Akt, 
phosphorylation of Akt at Ser473 was measured by western blots in male offspring mice.
6B-E. Relative gene expressions are shown as ratios of IRS1/GAPDH, Phospho-IRS-1-
Ser636/ IRS-1, Akt/GAPDH, Phospho-Akt (Ser473)/ Akt.
6F. The expression of Igf1, Insig1, Insig2a, Insr, Lepr, Adipor1, and Adipor2 was measured 
by RT-PCR in the liver of male offspring mice.
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Mice were sacrificed under a fasting status, thus the Insulin and AKT signaling is measured 
at basal level. Data is presented as Mean ± SE, n = 5 from 5 litters. * P < 0.05 vs. REF 
group. # P < 0.05 vs. NF group.
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Figure7. The maternal HF and H1N diets inhibited the hepatic AMPK signaling activity and 
overexpression of β-oxidation related genes, while the H9N diet avoided such effects.
7A. The expression of AMPK-α, phosphorylation of AMPK-α, and PPAR-α were detected 
by western blots in male offspring mice.
7B-E. Relative expressions were expressed as ratios of AMPK-α/GAPDH (B), Phospho- 
AMPK-α/GAPDH (C), Phospho- AMPK-α/ AMPK-α (D) and PPAR-α/ GAPDH(E).
7F. L-Carnitine content was detected via high-resolution UPLC-MS/MS method.
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7G. The hepatic expression of key genes for fatty acid degradation and β-oxidation, 
including Cpt1a, Cpt1b, Cpt2, Hmgcs2, Mlycd, and Acsl1 of male offspring mice was 
measured by RT-PCR.
Data is presented as Mean ± SE, n = 5 from 5 litters. * P < 0.05 vs. REF group. # P < 0.05 
vs. NF group.
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Table 1.
Study Design for maternal diet transition from HF to NF diet before pregnancy.
Maternal Diet Offspring Diet
Pre-pregnancy Transition Pregnancy/Lactation After Weaning
REF (n=15) CD - CD CD
NF (n=15) NF - NF HF
HF (n=15) HF - HF HF
H1N (n=15) HF NF (1 week) NF HF
H9N (n=15) HF NF (9 weeks) NF HF
*
Diet description:
REF Rodent diet: normal chow diet (CD, 4% kcal. from fat)
NF Rodent diet: 10% kcal from fat.
HF Rodent diet: 60% kcal from fat.
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Table 2.
Primers used for mRNA quantification by real-time PCR
Gene Forward primer 5′–3′ Reverse primer 5′–3′
Srebf1 TGACCCGGCTATTCCGTGA CTGGGCTGAGCAATACAGTTC
Fasn GGAGGTGGTGATAGCCGGTAT TGGGTAATCCATAGAGCCCAG
Acc1 ATCCAGGCCATGTTGAGACG AGATGTGCTGGGTCATGTGG
Acc2 CGCTCACCAACAGTAAGGTGG GCTTGGCAGGGAGTTCCTC
Elovl6 GAAAAGCAGTTCAACGAGAACG AGATGCCGACCACCAAAGATA
Scd1 TTCTTGCGATACACTCTGGTGC CGGGATTGAATGTTCTTGTCGT
Cd36 GAACCAAACTGAGGAATGGATCT GAACCAAACTGAGGAATGGATCT
Srebf2 GCAGCAACGGGACCATTCT CCCCATGACTAAGTCCTTCAACT
Cyp51 AACGAAGACCTGAATGCAGAAG GTGGGCTATGTTAAGGCCACT
Hmgcr AGCTTGCCCGAATTGTATGTG TCTGTTGTGAACCATGTGACTTC
Hmgcs1 AAATGCCAGACCTACAGGTGG ATGCTGCATGTGTGTCCCA
Hmgcs2 GAAGAGAGCGATGCAGGAAAC GTCCACATATTGGGCTGGAAA
Abca1 GCTTGTTGGCCTCAGTTAAGG GTAGCTCAGGCGTACAGAGAT
Ldlr AGAGCCTGTGCCGAGATGT TGGTCTGAGTAGATCCAGGAGT
Pcsk9 TTGCCCCATGTGGAGTACATT GGGAGCGGTCTTCCTCTGT
Igf1 CTGGACCAGAGACCCTTTGC GGACGGGGACTTCTGAGTCTT
Insig1 CTAGTGCTCTTCTCATTTGGCG AGGGATACAGTAAACCGACAACA
Insig2a GGAGTCACCTCGGCCTAAAAA CAAGTTCAACACTAATGCCAGGA
Insr TCAAGACCAGACCCGAAGATT TCTCGAAGATAACCAGGGCATAG
Lepr ATGTGCCCTTCCGATATACAACC CGTGTCATCCACTAATCTTCTGG
Adipor1 AGACAACGACTACCTGCTACA GTGGATGCGGAAGATGCTCT
Adipor2 GGAGTGTTCGTGGGCTTAGG GCAGCTCCGGTGATATAGAGG
Cpt1a CTCCGCCTGAGCCATGAAG CACCAGTGATGATGCCATTCT
Cpt1b GCACACCAGGCAGTAGCTTT CAGGAGTTGATTCCAGACAGGTA
Cpt2 CAAAAGACTCATCCGCTTTGTTC CATCACGACTGGGTTTGGGTA
Acsl1 CGCACCCTTCCAACCAACA CGCTATTTCCACTGACTGCAT
Mlycd GCACGTCCGGGAAATGAAC GCCTCACACTCGCTGATCTT
B2m* TTCTGGTGCTTGTCTCACTGA CAGTATGTTCGGCTTCCCATTC
*B2m was selected as the internal control.
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Table 3.
Cone and collision energy voltage and MRM mass transitions used for L-Carnitine detection
Analyte Cone voltage (V) Collision energy (V) Precursor ion (m/z) Product ion (m/z) Retention time (min)
L-carnitine 30 20 162 85 4.3
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